Following a comprehensive review, the National Institute for Health and Care Excellence (NICE)’s Medical Technology Guidance has recommended Debrisoft pad (10x10cm), Debrisoft Lolly and Debrisoft pad (13x20cm), manufactured by Lohmann & Rauscher, as part of the management of acute or chronic wounds in the community.
Following a comprehensive review, the National Institute for Health and Care Excellence (NICE)’s Medical Technology Guidance has recommended Debrisoft pad (10x10cm), Debrisoft Lolly and Debrisoft pad (13x20cm), manufactured by Lohmann & Rauscher, as part of the management of acute or chronic wounds in the community.
The NICE committee behind the guidance concluded that using the Debrisoft family would improve speed of debridement, reduce costs and result in a reduction in nursing visits compared to saline and gauze, hydrogel and larvae.
The Debrisoft range (L&R Medical UK) are sterile and single-use monofilament debridement devices intended for nurses and other healthcare professionals to use on adults and children to remove devitalised tissue, debris, and hyperkeratotic skin around acute or chronic wounds. For more information on the Debrisoft range click here: https://lohmann-rauscher.co.uk/woundcare/debrisoft
To read the NICE guidance in full click here: https://www.nice.org.uk/guidance/mtg17
